Antiviral Activity of a Small-Molecule Inhibitor of Filovirus Infection

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2010-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/AAC.01315-09PMID 20211898PMCID PMC2863630
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outbreak news. Ebola Reston in pigs and humans, Philippines.

  2009cited by this paper
• Development of a broad-spectrum antiviral with activity against Ebola virus.

  2009cited by this paper
• Response to Imported Case of Marburg Hemorrhagic Fever, the Netherlands

  2009cited by this paper
• Scientists Puzzle Over Ebola-Reston Virus in Pigs

  2009cited by this paper
• Development and Characterization of a Mouse Model for Marburg Hemorrhagic Fever

  2009cited by this paper
• FGI-104: a broad-spectrum small molecule inhibitor of viral infection.

  2009influential reference
• Filoviruses: A Compendium of 40 Years of Epidemiological, Clinical, and Laboratory Studies

  2008influential reference
• Filoviruses. A compendium of 40 years of epidemiological, clinical, and laboratory studies.

  2008cited by this paper
• Managing Potential Laboratory Exposure to Ebola Virus by Using a Patient Biocontainment Care Unit

  2008cited by this paper
• Filoviruses: Interactions with the host cell

  2007cited by this paper
• Regulation of the Interferon System : Evidence that Vero Cells have a Genetic Defect in Interferon Production

  2007cited by this paper
• Involvement of vacuolar protein sorting pathway in Ebola virus release independent of TSG101 interaction.

  2007cited by this paper
• Development of a model for marburgvirus based on severe-combined immunodeficiency mice

  2007cited by this paper
• Outbreak of Marburg virus hemorrhagic fever--Angola, October 1, 2004-March 29, 2005.

  2005cited by this paper
• Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening.

  2005influential reference
• In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding

  2003cited by this paper
• Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection.

  2003cited by this paper
• 3-deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice.

  2002cited by this paper
• Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily.

  2002cited by this paper
• HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress

  2001cited by this paper
• Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice.

  2001cited by this paper
• Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor.

  2000cited by this paper
• A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.

  1998cited by this paper
• A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.

  1998cited by this paper
• Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production.

  1979cited by this paper
• Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent.

  1973cited by this paper

• Marburg Virus Disease: A Narrative Review

  2025cites this paper
• Recent Advances in Therapeutic Approaches Against Ebola Virus Infection.

  2024cites this paper
• Fluorescent and bioluminescent reporter mouse-adapted Ebola viruses maintain pathogenicity and can be visualized in vivo.

  2023cites this paper
• COMPUTATIONAL STUDIES OF POTENTIAL EBOLA VP40 INHIBITORS USING BIOACTIVE COMPOUNDS FROM MEDICINAL PLANTS OF MALAYSIA

  2022cites this paper
• In-silico Structural and Molecular Docking-Based Drug Discovery Against Viral Protein (VP35) of Marburg Virus: A potent Agent of MAVD

  2021cites this paper
• Comparison of Zaire and Bundibugyo Ebolavirus Polymerase Complexes and Susceptibility to Antivirals through a Newly Developed Bundibugyo Minigenome System

  2021cites this paper
• Ubiquitin‐specific protease 14 is a new therapeutic target for the treatment of diseases

  2020cites this paper
• Immunological Perspective for Ebola Virus Infection and Various Treatment Measures Taken to Fight the Disease

  2020cites this paper
• Murine Models for Development of Anti-Infective Therapeutics

  2020cites this paper
• Discovery and Structural Optimization of 4-(Aminomethyl)benzamides as Potent Entry Inhibitors of Ebola and Marburg Virus Infections.

  2020cites this paper
• A Focus on Ebola Virus Polymerase

  2019cites this paper
• Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action.

  2019cites this paper
• Review on the Epidemiology and Public Health Importance of Marburg Hemorrhagic Fever in Africa

  2019cites this paper
• One-Pot Synthesis of Unsymmetrical Bis-Heterocycles: Benzimidazole-, Benzoxazole-, and Benzothiazole-Linked Thiazolidines.

  2019cites this paper
• Viral Therapeutics

  2019cites this paper
• Ebola Virus Disease: Biology, Diagnosis, Treatment and Prevention of Epidemics

  2017cites this paper
• Ebola Virus Infection: a review on the pharmacokinetic and pharmacodynamic properties of drugs considered for testing in human efficacy trials

  2017cites this paper
• Filovirus Strategies to Escape Antiviral Responses.

  2017cites this paper
• Reverse Genetics of Filoviruses.

  2017cites this paper
• Ebola and Marburg: Out of Africa

  2017cites this paper
• Assessment of Inhibition of Ebola Virus Progeny Production by Antiviral Compounds.

  2017cites this paper
• The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection.

  2016cites this paper
• Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials

  2016cites this paper
• Post-exposure treatment of Ebola virus disease in guinea pigs using EBOTAb, an ovine antibody-based therapeutic

  2016cites this paper
• AVANCES CIENTÍFICOS EN LAS ESTRATEGIAS TERAPÉUTICAS CONTRA LA ENFERMEDAD POR VIRUS DEL ÉBOLA

  2016cites this paper
• How treat viral infections in ICU patients.

  2016cites this paper
• Neglected filoviruses.

  2016influential citation
• Apoptosis is a Major Pathogenic Event for Several Important Viral and Bacterial Pathogens

  2015influential citation
• Ebola virus – current threats and perspectives for control of infections

  2015cites this paper
• Clinical Management of Ebola Virus Disease: Current and Future Approaches

  2015cites this paper
• Development of experimental and early investigational drugs for the treatment of Ebola virus infections

  2015cites this paper
• State-of-the-Art Workshops on Medical Countermeasures Potentially Available for Human Use Following Accidental Exposures to Ebola Virus.

  2015cites this paper
• Ebola Virus Infection: Overview and Update on Prevention and Treatment

  2015cites this paper
• Calcium Regulation of Hemorrhagic Fever Virus Budding: Mechanistic Implications for Host-Oriented Therapeutic Intervention

  2015cites this paper
• Pathophysiology of Ebola Virus Infection: Current Challenges and Future Hopes.

  2015cites this paper
• Filoviruses: One of These Things is (not) Like the Other

  2015cites this paper
• Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks

  2015cites this paper
• The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target.

  2015cites this paper
• Small molecule inhibitors of ebola virus infection.

  2015cites this paper
• Development of Small‐Molecule Antivirals for Ebola

  2015cites this paper
• Therapeutics for postexposure treatment of Ebola virus infection.

  2015cites this paper
• Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430

  2014cites this paper
• Reverse genetics systems as tools for the development of novel therapies against filoviruses

  2014cites this paper
• The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus.

  2014cites this paper
• Animal models of viral hemorrhagic fever.

  2014cites this paper
• How to approach and treat viral infections in ICU patients

  2014cites this paper
• Retinazone Inhibits Certain Blood-Borne Human Viruses Including Ebola Virus Zaire

  2014influential citation
• Ebola virus (EBOV) infection: Therapeutic strategies

  2014influential citation
• Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses.

  2013cites this paper
• Emerging Targets and Novel Approaches to Ebola Virus Prophylaxis and Treatment

  2013cites this paper
• Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents

  2013cites this paper
• Antiviral options for biodefense.

  2013influential citation
• A Cutting‐Edge View on the Current State of Antiviral Drug Development

  2013cites this paper
• Intervention strategies for emerging viruses: use of antivirals

  2013cites this paper
• Protein-protein and protein-small-molecule inhibitor interactions in the measles virus replication complex

  2013cites this paper
• Marburg Virus Disease

  2013cites this paper
• Human viral diseases: what is next for antiviral drug discovery?

  2012cites this paper
• Human viral diseases: what is next for antiviral drug discovery?

  2012cites this paper
• Investigation of Ebola VP40 assembly and oligomerization in live cells using number and brightness analysis.

  2012cites this paper
• Potential Vaccines and Post-Exposure Treatments for Filovirus Infections

  2012influential citation
• Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design

  2012cites this paper
• Forty-Five Years of Marburg Virus Research

  2012cites this paper
• Mouse Models for Filovirus Infections

  2012cites this paper
• Ebolavirus: a brief review of novel therapeutic targets.

  2012cites this paper
• Identification of a Small-Molecule Entry Inhibitor for Filoviruses

  2011cites this paper
• Les fièvres hémorragiques à virus Ebola et Marburg: l'actualité des filovirus

  2011cites this paper
• Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies

  2011cites this paper
• A chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus.

  2011cites this paper
• Identification of a Small-Molecule Entry Inhibitor for Filoviruses (cid:1)

  2011cites this paper
• Correlates of Immunity to Filovirus Infection

  2011cites this paper
• Developments in antivirals against influenza, smallpox and hemorrhagic fever viruses

  2011cites this paper
• A combination of DNA vaccination and a recombinant adenovirus serotype 5 boost resulted in cross-protective immunity in non-human primates. A recombinant vesicular stomatitis vaccine vector protected non-human primates

  2011cites this paper
• Evaluation of Perceived Threat Differences Posed by Filovirus Variants

  2011cites this paper
• Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry

  2011cites this paper
• Clinical aspects of Marburg hemorrhagic fever.

  2011cites this paper
• Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa.

  2011cites this paper